Covington, Davis Polk Lead Eikon's Upsized $381M IPO
By Jade Martinez-Pogue · February 5, 2026, 2:45 PM EST
Oncology-focused biopharmaceutical company Eikon Therapeutics began trading publicly Thursday after raising $381 million in its upsized initial public offering....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login